The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling
Inflammation and proinflammatory cytokines have been implicated in the progression of benign prostatic hyperplasia (BPH). Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine. Our previous study found that MIF is highly expressed in BPH epithelium. It has been reported that the...
Main Authors: | Hualin Song, Qi Shen, Shuai Hu, Jie Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2020-11-01
|
Series: | Biology Open |
Subjects: | |
Online Access: | http://bio.biologists.org/content/9/11/bio053447 |
Similar Items
-
Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01) -
Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats
by: Woo-Young Jeon, et al.
Published: (2017-08-01) -
Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
by: Sung Han Kim, et al.
Published: (2021-04-01) -
Role of prostatic artery embolization in management of symptomatic benign prostatic hyperplasia
by: Mohamed Shaker, et al.
Published: (2016-09-01) -
THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)